变量 | 总数(N = 102) | 存活者(n = 75) | 死亡(n = 27) | P值 |
性别男 | 76.5% | 73% | 81% | 0.56 |
年龄 | 64.74 ± 7.85 | 64.14 ± 7.43 | 66.41 ± 8.83 | 0.200 |
体重 | 67.83 ± 9.15 | 67.42 ± 8.96 | 68.94 ± 9.75 | 0.458 |
共病 |
|
|
|
|
COPD | 27.5% | 13.5% | 66.7% | <0.001 |
高血压 | 45.1% | 48.6% | 37% | 0.302 |
2型糖尿病 | 31.4 | 36.5% | 18.5% | 0.092 |
术前EF | 29.19 ± 5 | 29.77 ± 4.677 | 27.59% ± 5.58 | 0.008 |
术后EF | 30.55 ± 4.84 | 31.01 ± 3.52 | 29.30 ± 7.27 | 0.016 |
颈动脉狭窄 | 11.8% | 9.8% | 18.5% | 0.23 |
心绞痛 | 52% | 51.4% | 55.6% | 0.708 |
陈旧性心肌梗死 | 43.1% | 43.2% | 44.4% | 0.914 |
心功能分级(NYHA) |
|
|
| 0.53 |
>I | 0 | 0 | 0% |
|
>II | 9.8% | 8.1% | 14.8% |
|
>III | 52.9% | 59.5% | 37% |
|
>IV | 36.3% | 32.4% | 48.1 |
|
手术时机 |
|
|
|
|
急诊手术 | 13.7% | 9.5% | 25.9% | 0.034 |
择期手术 | 84.3% | 91.5% | 74.1% | 0.06 |
二次手术 | 9.8% | 12.2% | 3.7% | 0.304 |
术前IABP应用 | 31.4% | 21.6% | 59.3% | 0.001 |
术前慢性药物治疗 |
|
|
|
|
利尿剂 | 39.2% | 37% | 48.1% | 0,314 |
抗血小板药物 | 32.4% | 28.4% | 44.4% | 0.131 |
β受体阻滞剂 | 50% | 51.4% | 52% | 0.95 |
抗生素 | 22.5% | 20.3% | 29.6% | 0.324 |
钙离子通道阻滞剂 | 19.6% | 17.8% | 25.9% | 0.323 |
手术处理 |
|
|
|
|
合并二尖瓣手术 | 24.5% | 16.2% | 48.1% | 0.002 |
合并三尖瓣手术 | 14.7% | 12.2% | 22.2% | 0.215 |
合并主动脉瓣手术 | 9.8% | 8.1% | 7.7% | 0.325 |
合并左心室手术 | 14.7% | 14.9% | 14.8% | 0.995 |